Navigation Links
Intrahepatic cholestasis during pregnancy predisposes to later liver disease

In a preliminary investigation it has been found that if there is Intrahepatic cholestasis during pregnancy women are more susceptible to liver disease late on.//

This case control study was performed in Finland on 21,008 women and found the above mentioned result. Intrahepatic cholestasis of pregnancy (ICP) is an itchy skin condition when bile gets backed up in the liver.

The study is published in the April 2006 issue of Hepatology, the official journal of the American Association for the Study of Liver Diseases (AASLD).

ICP occurs in one percent of pregnancies, causing intense skin itching and elevated levels of liver enzymes and bile acids

Anne Ropponen, M.D. of the Department of Obstetrics and Gynecology at Helsinki University Central Hospital led a team of researchers and designed a cohort study using cases recorded in the Finnish Hospital Discharge Register between 1972 and 2000. no previous study had dealt this aspect. 10,504 women with a history of ICP were taken and matched to controls without ICP based on age at, site of, and time of delivery. They studied a total of 21,008 women, and collected information on their subsequent hospitalizations.

Statistically significant differences in the incidence of several liver and biliary diseases were noted and women who had ICP were significantly more likely to later be diagnosed with hepatitis C, non-alcoholic cirrhosis, gallstones, cholecystitis and non-alcoholic pancreatitis.

According to the authors, "After all the conservative analyses performed in this study, we conclude that there is an association between ICP and several liver and biliary diseases. The results suggest that in a subgroup of patients, ICP may not only be the self-limiting, spontaneously resolving condition that it has been thought to be, but also an indicator of subsequent, often more serious diseases. To resolve the cause of association we have identified, further studies are cle arly indicated."


'"/>




Related medicine news :

1. IMA wants members not to do sex determination tests during pregnancy
2. Heart Attacks during Menstruation!
3. Waking during surgery
4. Cigerettes unsafe during pregnancy
5. Strokes increased during squatting
6. Smoking during pregnancy increases risk of cleft palate
7. Light therapy decreases depression during pregnancy
8. Watch what you eat during summer
9. Drink more fluids during exercise
10. Air pollution hits heart patients during exercise
11. Enduring anti-clotting treatment avails heart patients
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/23/2017)... Cranbury, NJ (PRWEB) , ... February 23, 2017 ... ... disease media outlet with a clinician-based audience, will be participating in Rare Disease ... 2017, in Washington, D.C. In addition, Rare Disease Report, a website, weekly e-newsletter ...
(Date:2/23/2017)... ... February 23, 2017 , ... Hamlin Dental Group and Dr. Hamid Reza, ... a raffle. Throughout the month of February, patients who visit Hamlin Dental Group will ... a dinner for two at the Cheesecake Factory. , Tickets are available for ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... host a diverse symposium on “Doping in Sport: How the Culture Might ... Richter & Hampton LLP. The symposium will be held at Pepperdine University in ...
(Date:2/23/2017)... ... February 23, 2017 , ... ERT, a ... today announced that Premier Research, a leading clinical development service provider, has selected ... becoming increasingly complex, due in part to an array of circumstances including the ...
(Date:2/23/2017)... ... February 23, 2017 , ... The ... the Rhode Island Consortium for Autism Research and Treatment (RI-CART) and Cinemaworld to ... autism spectrum disorder (ASD) to see films in an environment that accommodates their ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... 2017  This report analyzes the worldwide markets for ... Products: Intermediates, Analytical, and Others. The End ... and Agrochemicals. The report provides separate comprehensive analytics for ... Europe , and Rest of World. Annual estimates ... 2022. Also, a six-year historic analysis is provided for ...
(Date:2/24/2017)...  Xynomic Pharmaceuticals, Inc., an oncology drug research ... acquired exclusive worldwide rights to develop, manufacture and ... targeting hematological and solid tumors. To ... 2 clinical trials of Abexinostat in US, EU ... been completed, demonstrating that Abexinostat is clinically active ...
(Date:2/23/2017)... NEW YORK , Feb. 23, 2017  Genesis ... HME Company. The announcement was made by Bill ... David Hartley and Nathan Feltman , ... of Genesis Healthcare Services, LLC. This ... nation,s largest provider of technology enabled durable medical equipment ...
Breaking Medicine Technology: